ChartRow logo
Data provided bySource: Twelve Data
Share this page

TECH financial statements

The full income statement, balance sheet, and cash-flow statement for Bio-Techne (TECH), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +5.5%10Y CAGR +9.3%YoY +4.6%
$1.2B TTM$299.7M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Gross profit

5Y CAGR +4.8%10Y CAGR +9.0%YoY +4.5%
$807.6M TTM$196.6M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Operating income

5Y CAGR +1.2%10Y CAGR +5.3%YoY −23.2%
$240.8M TTM$36.6M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Net income

5Y CAGR +5.3%10Y CAGR +5.7%YoY −25.9%
$172M TTM$28.3M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

EPS (diluted)

5Y CAGR +5.9%10Y CAGR +5.2%YoY −25.0%
$1.09 TTM$0.18 Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Operating cash flow

5Y CAGR −3.7%10Y CAGR +7.3%YoY +165.0%
$337.6M TTM$73.1M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Capital expenditure

5Y CAGR −8.2%10Y CAGR +5.5%YoY +10.3%
$29.4M TTM$5.9M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Free cash flow

5Y CAGR −3.1%10Y CAGR +7.5%YoY +202.4%
$308.2M TTM$67.2M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Shares (diluted)

5Y −3.0%10Y +5.2%YoY +1.0%
157.4M TTM157.9M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Dividend per share

5Y CAGR +0.0%10Y CAGR +0.0%YoY +0.0%
$0.32 TTM$0.08 Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Every TECH chart on Trends →

Shares outstanding (point-in-time)

2024-09 158.9M2024-12 158.1M2025-03 156.8M2025-06 155.5M2025-09 155.8M2025-12 156.5M2026-03 156.6M2026-06 156.8M2026-09 157.1M-1.2% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2026FY2025FY2024FY2023FY2022
Income Statementas ofJun 30 ’26as ofJun 30 ’25as ofJun 30 ’24as ofJun 30 ’23as ofJun 30 ’22
Revenue1.22B-0.4%1.22B+5.2%1.16B+2.0%1.14B+2.8%1.11B+18.7%
799M+1.1%790M+2.7%770M-0.0%770M+1.8%756M+19.5%
Cost of revenue416M-3.1%429M+10.3%389M+6.1%367M+5.1%349M+17.1%
547M-20.5%688M+22.2%563M+19.6%471M+2.4%460M+16.3%
Research & development94.8M-4.8%99.5M+2.9%96.7M+4.5%92.5M+6.1%87.1M+23.4%
Selling, general & administrative452M-23.1%589M+26.2%466M+23.3%378M+1.5%373M+14.7%
Restructuring2.08M-81.8%11.5M+242.5%3.35M-12.5%3.83M+133.5%1.64M+1054.9%
Amortization of intangibles61.8M-18.7%76.0M+63.2%46.6M-39.9%77.5M+4.5%74.1M+14.2%
Operating income252M+146.3%102M-50.5%207M-30.9%299M+0.8%297M+25.0%
Interest expense9.63M+13.2%8.51M-45.9%15.7M+40.3%11.2M-0.8%11.3M-18.9%
Other non-operating income-5.80M-798.3%831K+109.7%-8.58M-118.1%47.5M+210.4%15.3M+120.2%
Equity-method income887K-5.4%938K+113.7%-6.84M-498.5%-1.14M—
Pre-tax income241M+144.4%98.5M-47.0%186M-45.2%339M+12.4%301M+103.4%
Income tax58.8M+134.7%25.1M+42.5%17.6M-67.0%53.2M+39.0%38.3M+345.7%
182M+147.8%73.4M-56.3%168M-41.1%285M+4.9%272M+93.8%
Net income to non-controlling interest———179K+102.0%-8.95M-985.1%
Net income to common182M+147.9%73.4M-56.4%168M-41.1%285M+4.9%272M+93.8%
$1.16+152.2%$0.46-56.2%$1.05-40.3%$1.76+6.0%$1.66+90.8%
EPS (basic)$1.17+148.9%$0.47-56.1%$1.07-40.9%$1.81+4.6%$1.73+90.1%
Weighted-avg shares (basic)156M-1.0%158M-0.1%158M+0.3%157M+0.2%157M+1.2%
Weighted-avg shares (diluted)157M-1.7%160M-0.7%161M-0.7%162M-1.4%164M+1.3%
Dividends per share$0.32+0.0%$0.32+0.0%$0.32+0.0%$0.32+0.0%$0.32+0.0%
Balance Sheetas ofJun 30 ’26as ofJun 30 ’25as ofJun 30 ’24as ofJun 30 ’23as ofJun 30 ’22
744M+22.4%608M-1.5%617M-0.7%621M+2.6%606M+18.6%
Cash & equivalents265M+63.2%162M+6.8%152M-15.9%181M+4.6%173M-13.3%
Short-term investments——1.07M-95.5%23.7M-68.1%74.5M+129.4%
Accounts receivable217M+4.7%207M-14.3%241M+10.5%218M+12.3%195M+33.8%
Inventory196M+3.3%189M+5.4%180M+4.7%172M+21.6%141M+20.9%
Other current assets67.4M+79.8%37.5M+11.3%33.7M+24.4%27.1M+18.4%22.9M+35.1%
2.59B+1.1%2.56B-5.4%2.70B+2.5%2.64B+15.0%2.29B+1.4%
Property, plant & equipment232M-5.6%246M-2.2%251M+11.0%226M+1.3%223M+7.4%
Operating lease right-of-use67.3M-8.3%73.4M-19.6%91.3M-7.2%98.3M+50.0%65.6M-11.2%
Goodwill975M-0.6%981M+0.9%973M+11.4%873M+6.2%822M-2.5%
Intangible assets303M-17.0%366M-27.9%507M-5.2%535M+0.6%532M-13.7%
Deferred tax assets
—10.3M———
Other non-current assets264M-6.9%284M+7.4%264M-7.4%285M+509.3%46.8M+304.6%
164M-6.9%176M+10.3%159M+24.0%129M-27.0%176M+15.6%
Accounts payable26.7M+5.5%25.3M-33.3%38.0M+47.9%25.7M-24.2%33.9M+15.2%
Accrued liabilities20.5M-20.3%25.7M+3.1%24.9M+67.2%14.9M-16.8%17.9M+17.0%
Deferred revenue36.1M+10.7%32.6M+16.6%27.9M+21.1%23.1M-1.4%23.4M+23.2%
Short-term & current debt
————12.5M+0.0%
Current lease liability14.9M+5.9%14.1M+9.1%12.9M+15.4%11.2M-6.1%11.9M+2.8%
Other current liabilities4.03M+144.7%1.65M-23.5%2.15M+52.2%1.41M+13.7%1.24M-68.1%
—639M+0.6%635M-5.5%672M+13.2%594M-14.2%
Long-term debt200M-42.2%346M+8.5%319M-8.9%350M+43.8%243M-26.0%
Non-current lease liability74.2M-11.7%84.0M-4.2%87.6M-6.6%93.8M+61.3%58.1M-14.0%
Operating lease liability (total)89.1M-9.1%98.1M-2.5%101M-4.2%105M+49.8%70.1M-11.6%
Deferred tax liabilities19.3M+213.0%6.17M-89.0%55.9M-37.2%89.0M-10.1%99.0M+6.3%
Other non-current liabilities21.3M-21.2%27.1M+105.8%13.2M+20.5%10.9M-10.8%12.2M-50.0%
2.11B+9.9%1.92B-7.3%2.07B+5.2%1.97B+15.6%1.70B+8.9%
Common stock1.56M+0.7%1.55M-2.0%1.58M+0.4%1.58M+0.6%1.57M+301.5%
Additional paid-in capital1.03B+13.4%911M+11.1%820M+13.7%722M+10.6%652M+22.1%
Retained earnings1.14B+7.3%1.07B-19.6%1.33B+1.2%1.31B+16.6%1.12B+3.5%
Accumulated other comprehensive income-70.6M-17.9%-59.9M+23.5%-78.3M-18.5%-66.1M+12.1%-75.2M-31.3%
Non-controlling interest
————-759K-109.2%
Total equity incl. non-controlling2.11B+9.9%1.92B-7.3%2.07B+5.2%1.97B+15.6%1.70B+8.3%
Total liabilities & equity2.59B+1.1%2.56B-5.4%2.70B+2.5%2.64B+15.0%2.29B+1.4%
Common shares issued156M+0.7%155M-2.1%158M+0.4%158M+0.6%157M+0.5%
Common shares outstanding156M+0.7%155M-2.1%158M+0.4%158M+0.6%157M+0.5%
Shares outstanding (cover)157M+0.8%156M-1.9%159M+0.3%158M+0.8%157M+0.3%
Cash Flowas ofJun 30 ’26as ofJun 30 ’25as ofJun 30 ’24as ofJun 30 ’23as ofJun 30 ’22
292M+1.6%288M-3.8%299M+17.5%254M-21.8%325M-7.6%
Depreciation & amortization97.4M-11.4%110M-1.6%112M+4.2%107M+6.1%101M+15.2%
Intangible amortization61.8M-18.7%76.0M+63.2%46.6M-39.9%77.5M+4.5%74.1M+14.2%
Share-based compensation41.4M+1.3%40.8M+7.3%38.0M-3.0%39.2M-7.0%42.2M-13.9%
Deferred income taxes23.7M+146.3%-51.2M-27.4%-40.2M-34.8%-29.8M-521.9%7.06M+125.2%
Change in inventory8.23M-54.6%18.1M+27.6%14.2M-52.9%30.2M-5.7%32.0M+348.3%
Other operating activities477K-66.5%1.43M+38.4%1.03M+6158.8%-17.0K-102.5%668K+244.0%
-18.2M+48.3%-35.2M+82.7%-203M+23.6%-266M-174.3%-96.9M+60.2%
Capital expenditure28.9M-7.0%31.0M-50.7%62.9M+64.4%38.2M-14.8%44.9M+1.4%
Free cash flow263M+2.6%257M+8.7%236M+9.2%216M-22.9%280M-8.9%
Acquisitions0.000.00-100.0%170M+67.7%101M0.00-100.0%
Sales/maturities of investments———35.2M+35.2%26.1M-60.7%
-169M+33.4%-254M-107.4%-122M-641.2%22.6M+109.3%-243M-288.2%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00
Common stock repurchased41.7M-84.9%276M+244.5%80.0M+309.2%19.6M-87.8%161M+272.8%
Dividends paid49.9M-0.9%50.4M-0.1%50.4M+0.3%50.3M+0.2%50.2M+1.1%
Other financing activities———-2.46M-411.8%788K+104.1%
Net change in cash103M+886.3%10.4M+136.1%-28.8M-459.6%8.00M+130.2%-26.5M-150.6%
Interest paid14.4M-24.1%19.0M+30.7%14.5M+73.3%8.37M-24.1%11.0M-18.8%
Income taxes paid64.1M-13.7%74.4M+14.0%65.3M-26.2%88.4M+191.4%30.3M+44.8%
Valuation Ratiosas ofJun 30 ’26as ofJun 30 ’25as ofJun 30 ’24as ofJun 30 ’23as ofJun 30 ’22
Market cap11.0B+38.3%7.97B-29.4%11.3B-12.3%12.9B-5.2%13.6B-22.6%
P/E60.6×-44.2%108.6×+95.3%55.6×+23.3%45.1×-9.6%49.9×-60.1%
P/S9.1×+38.8%6.5×-33.2%9.8×-13.6%11.3×-7.8%12.3×-34.8%
P/B5.2×+25.9%4.2×-25.9%5.6×-14.3%6.5×-18.0%8.0×-28.9%
P/FCF41.9×+34.8%31.1×-30.9%45.0×-24.5%59.5×+23.0%48.4×-15.0%
Earnings yield1.6%+79.2%0.92%-48.8%1.8%-18.9%2.2%+10.6%2.0%+150.4%
FCF yield2.4%-25.8%3.2%+44.7%2.2%+32.4%1.7%-18.7%2.1%+17.7%
Dividend yield0.45%-27.2%0.62%+39.3%0.45%+13.9%0.39%+6.2%0.37%+29.9%
Source filing10-K10-K10-K10-K10-K
Fiscal yearCEOTotal, as reportedActually paidOther executives, average$100 in the stock$100 in peers
FY2025Kelderman $8.2M / $2.5MKeldeman — / $2.5M$8.2M$4.9M$3.7M$79.49$103.58
FY2024Kelderman $2.6M / $2.8MKummeth $6.8M / $4.8MKemmeth — / $4.8MKeldeman — / $2.8M$9.4M$15.3M$3.3M$110.17$131.47
FY2023Kummeth $30.6M / $4.7MKemmeth — / $4.7M$30.6M$9.4M$2.3M$124.96$126.72
FY2022Kummeth $15.4M / −$6.3MKemmeth — / −$6.3M$15.4M−$12.7M$3.2M$132.17$129.72
FY2021Kummeth $15.9M / $105.7MKemmeth — / $105.7M$15.9M$211.4M$5M$171.17$147.61

From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.

About this data

Source: TECH’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all TECH filings on SEC EDGAR → Not investment advice.